• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于 MS 的提取候选蛋白质组生物标志物的 Enrichr 计算机分析突出了系统性硬化症中的致病途径。

Enrichr in silico analysis of MS-based extracted candidate proteomic biomarkers highlights pathogenic pathways in systemic sclerosis.

机构信息

Neurogenetics Department, The Cyprus Institute of Neurology and Genetics, 2371, Nicosia, Cyprus.

出版信息

Sci Rep. 2023 Feb 2;13(1):1934. doi: 10.1038/s41598-023-29054-5.

DOI:10.1038/s41598-023-29054-5
PMID:36732374
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9894849/
Abstract

Systemic sclerosis (SSc) is a rheumatic disease characterised by vasculopathy, inflammation and fibrosis. Its aetiopathogenesis is still unknown, and the pathways/mechanisms of the disease are not clarified. This study aimed to perform in silico analysis of the already Mass Spectrometry (MS)-based discovered biomarkers of SSc to extract possible pathways/mechanisms implicated in the disease. We recorded all published candidate MS-based found biomarkers related to SSc. We then selected a number of the candidate biomarkers using specific criteria and performed pathway and cellular component analyses using Enrichr. We used PANTHER and STRING to assess the biological processes and the interactions of the recorded proteins, respectively. Pathway analysis extracted several pathways that are associated with the three different stages of SSc pathogenesis. Some of these pathways are also related to other diseases, including autoimmune diseases. We observe that these biomarkers are located in several cellular components and implicated in many biological processes. STRING analysis showed that some proteins interact, creating significant clusters, while others do not display any evidence of an interaction. All these data highlight the complexity of SSc, and further investigation of the extracted pathways/biological processes and interactions may help study the disease from a different angle.

摘要

系统性硬化症(SSc)是一种以血管病变、炎症和纤维化为特征的风湿性疾病。其病因发病机制尚不清楚,疾病的途径/机制也不清楚。本研究旨在对已基于质谱(MS)发现的 SSc 生物标志物进行计算机分析,以提取可能与疾病相关的途径/机制。我们记录了所有已发表的与 SSc 相关的候选 MS 发现的生物标志物。然后,我们使用特定标准选择了一些候选生物标志物,并使用 Enrichr 进行途径和细胞成分分析。我们使用 PANTHER 和 STRING 分别评估记录蛋白的生物过程和相互作用。途径分析提取了与 SSc 发病机制的三个不同阶段相关的几个途径。其中一些途径也与其他疾病有关,包括自身免疫性疾病。我们观察到这些生物标志物位于几个细胞成分中,并涉及许多生物过程。STRING 分析显示,一些蛋白质相互作用,形成显著的簇,而另一些则没有显示出任何相互作用的证据。所有这些数据突出了 SSc 的复杂性,对提取的途径/生物过程和相互作用的进一步研究可能有助于从不同角度研究该疾病。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8486/9894849/5a6f78a5c582/41598_2023_29054_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8486/9894849/385af1c6b5e6/41598_2023_29054_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8486/9894849/55faffb0874f/41598_2023_29054_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8486/9894849/dda121493580/41598_2023_29054_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8486/9894849/5a6f78a5c582/41598_2023_29054_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8486/9894849/385af1c6b5e6/41598_2023_29054_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8486/9894849/55faffb0874f/41598_2023_29054_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8486/9894849/dda121493580/41598_2023_29054_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8486/9894849/5a6f78a5c582/41598_2023_29054_Fig4_HTML.jpg

相似文献

1
Enrichr in silico analysis of MS-based extracted candidate proteomic biomarkers highlights pathogenic pathways in systemic sclerosis.基于 MS 的提取候选蛋白质组生物标志物的 Enrichr 计算机分析突出了系统性硬化症中的致病途径。
Sci Rep. 2023 Feb 2;13(1):1934. doi: 10.1038/s41598-023-29054-5.
2
Comparative analysis of affected and unaffected areas of systemic sclerosis skin biopsies by high-throughput proteomic approaches.高通量蛋白质组学方法分析系统性硬化症皮肤活检的病变和非病变区域。
Arthritis Res Ther. 2020 May 7;22(1):107. doi: 10.1186/s13075-020-02196-x.
3
Candidate proteomic biomarkers in systemic sclerosis discovered using mass-spectrometry: an update of a systematic review (2014-2020).基于质谱的系统性硬化症候选蛋白生物标志物的研究进展:一项系统性综述的更新(2014-2020)。
Rom J Intern Med. 2021 May 8;59(2):101-111. doi: 10.2478/rjim-2020-0037. Print 2021 Jun 1.
4
Systemic sclerosis biomarkers discovered using mass-spectrometry-based proteomics: a systematic review.使用基于质谱的蛋白质组学发现的系统性硬化症生物标志物:一项系统综述。
Biomarkers. 2014 Aug;19(5):345-55. doi: 10.3109/1354750X.2014.920046. Epub 2014 May 16.
5
Proteomic Analysis of Human Scleroderma Fibroblasts Response to Transforming Growth Factor-ß.人硬皮病成纤维细胞对转化生长因子-β反应的蛋白质组学分析。
Proteomics Clin Appl. 2019 Jul;13(4):e1800069. doi: 10.1002/prca.201800069. Epub 2018 Sep 6.
6
The role of endothelial cells in the vasculopathy of systemic sclerosis: A systematic review.系统性硬皮病血管病变中内皮细胞的作用:系统评价。
Autoimmun Rev. 2017 Aug;16(8):774-786. doi: 10.1016/j.autrev.2017.05.024. Epub 2017 May 29.
7
Circulatory cytokeratin 17, marginal zone B1 protein and leucine-rich α2-glycoprotein-1 as biomarkers for disease severity and fibrosis in systemic sclerosis patients.循环细胞角蛋白 17、边缘区 B1 蛋白和富含亮氨酸的α2-糖蛋白 1 作为系统性硬化症患者疾病严重程度和纤维化的生物标志物。
Biochem Med (Zagreb). 2022 Oct 1;32(3):030707. doi: 10.11613/BM.2022.030707.
8
Genomic and genetic studies of systemic sclerosis: A systematic review.系统性硬化症的基因组学和遗传学研究:一项系统综述。
Hum Immunol. 2017 Feb;78(2):153-165. doi: 10.1016/j.humimm.2016.10.017. Epub 2016 Oct 29.
9
Interstitial Lung Disease in Patients With Systemic Sclerosis: Toward Personalized-Medicine-Based Prediction and Drug Screening Models of Systemic Sclerosis-Related Interstitial Lung Disease (SSc-ILD).系统性硬化症患者的间质性肺病:基于个体化医学的系统性硬化症相关间质性肺病(SSc-ILD)预测和药物筛选模型。
Front Immunol. 2020 Sep 4;11:1990. doi: 10.3389/fimmu.2020.01990. eCollection 2020.
10
Low RUNX3 expression alters dendritic cell function in patients with systemic sclerosis and contributes to enhanced fibrosis.RUNX3 低表达改变系统性硬化症患者树突状细胞功能,并促进纤维化增强。
Ann Rheum Dis. 2019 Sep;78(9):1249-1259. doi: 10.1136/annrheumdis-2018-214991. Epub 2019 May 24.

引用本文的文献

1
Serum Proteomic Markers in Patients with Systemic Sclerosis in Relation to Silica Exposure.系统性硬化症患者血清蛋白质组学标志物与二氧化硅暴露的关系
J Clin Med. 2025 Mar 16;14(6):2019. doi: 10.3390/jcm14062019.
2
Immune Profiling of Patients with Systemic Sclerosis through Targeted Proteomic Analysis.通过靶向蛋白质组学分析对系统性硬化症患者进行免疫分析。
Int J Mol Sci. 2023 Dec 18;24(24):17601. doi: 10.3390/ijms242417601.
3
Identification of driving genes of familial adenomatous polyposis by differential gene expression analysis and weighted gene co-expression network analysis.
通过差异基因表达分析和加权基因共表达网络分析鉴定家族性腺瘤性息肉病的驱动基因。
Technol Health Care. 2024;32(3):1675-1696. doi: 10.3233/THC-230719.
4
Biomarkers in Systemic Sclerosis: An Overview.系统性硬化症中的生物标志物:概述
Curr Issues Mol Biol. 2023 Sep 25;45(10):7775-7802. doi: 10.3390/cimb45100490.
5
Biomarkers in the Pathogenesis, Diagnosis, and Treatment of Systemic Sclerosis.系统性硬化症发病机制、诊断及治疗中的生物标志物
J Inflamm Res. 2023 Oct 17;16:4633-4660. doi: 10.2147/JIR.S379815. eCollection 2023.